Cipla launches generic remdesivir for COVID-19 patients
PTI | 21 Jun 2020, 11:28 PMHomegrown pharma major Cipla Ltd announced the launch of its generic version of remdesivir, which has been authorised for emergency use in the treatment of COVID-19 patients by the USFDA, under its brand name Cipremi.